We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current BTMD market cap is 309.18M. The company's latest EPS is USD 0.0610 and P/E is 98.20.
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Total Revenue | 49.26M | 45.56M | 45.7M | 46.8M | 49.17M |
Operating Income | 7.67M | 7.6M | 5.51M | 10.43M | 6.23M |
Net Income | -5.14M | 7.53M | 7.73M | -2.07M | -6.32M |
Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 164.96M | 185.36M |
Operating Income | 0 | -3.32M | -60.72M | 28.66M |
Net Income | 0 | 11.11M | -969k | 3.32M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Total Assets | 139.05M | 149.75M | 155.3M | 160.11M | 92.9M |
Total Liabilities | 212.29M | 201.01M | 191.84M | 205.01M | 234.55M |
Total Equity | -73.24M | -51.27M | -36.55M | -44.9M | -141.65M |
Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 148k | 318.03M | 111.65M | 155.3M |
Total Liabilities | 123k | 340.66M | 169.92M | 191.84M |
Total Equity | 25k | -22.63M | -58.27M | -36.55M |
Quarter End | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
Operating | 19.77M | 19.93M | 26.88M | 7.37M | 17.32M |
Investing | -21.23M | -21.71M | -2.71M | -12.18M | -15.51M |
Financing | -9.29M | -11.86M | -14.38M | -5.41M | -64.38M |
Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | N/A | -1.37M | -9.16M | 26.88M |
Investing | N/A | -317.5M | -1.84M | -2.71M |
Financing | 2k | 319M | 63.46M | -14.38M |
Market Cap | 309.18M |
Price to Earnings Ratio | 98.20 |
Price to Sales Ratio | 1.76 |
Price to Cash Ratio | 3.66 |
Price to Book Ratio | -8.91 |
Dividend Yield | - |
Shares Outstanding | 54.34M |
Average Volume (1 week) | 260.76k |
Average Volume (1 Month) | 173.3k |
52 Week Change | 11.57% |
52 Week High | 8.44 |
52 Week Low | 3.6538 |
Spread (Intraday) | 2.09 (29.86%) |
Company Name | Biote Corporation |
Address |
251 little falls drive wilmington, delaware 19808 |
Website | https://www.biote.com |
Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions